Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Dendritic Cell Sarcoma, Interdigitating 76Sarcoma 72Burkitt Lymphoma 59Lymphoma 58Precursor Cell Lymphoblastic Leukemia-Lymphoma 56Lymphoma, Large B-Cell, Diffuse 54Lymphoma, Non-Hodgkin 53Lymphoma, Follicular 49Lymphoma, Mantle-Cell 48Leukemia 48Lymphoma, Large-Cell, Immunoblastic 47Leukemia, Lymphocytic, Chronic, B-Cell 46Lymphoma, B-Cell, Marginal Zone 45Leukemia, Myeloid, Acute 43Hodgkin Disease 42Myelodysplastic Syndromes 41Multiple Myeloma 40Recurrence 39Leukemia, Myeloid, Chronic-Phase 32Leukemia, Myeloid, Accelerated Phase 31Blast Crisis 30Neoplasms, Plasma Cell 28Sarcoma, Ewing 25Rhabdomyosarcoma 25Osteosarcoma 24Myeloproliferative Disorders 24Neuroblastoma 23Leukemia, Myelomonocytic, Chronic 21Congenital Abnormalities 21Melanoma 20

Interventions

Oncolytic Virotherapy 2repotrectinib 1pembrolizumab 1pamiparib 1interferon gamma-1b 1cixutumumab 1Vincristine 1Thiotepa 1Temozolomide 1Radiation 1Peripheral Blood Stem Cell Transplantation 1ONC206 1Melphalan 1Interferon-gamma 1Immunotherapy 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Erlotinib Hydrochloride 1Doxorubicin 1Cyclophosphamide 1Busulfan 1Bone Marrow Transplantation 1Antibodies, Monoclonal 1Amifostine 1Afatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroectodermal Tumors × Cyclophosphamide × Sarcoma × Clear all
NCT00001209 2008-03-04

A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
120 enrolled
Sarcoma

Sarcoma, Sarcoma, Ewing, Osteosarcoma, Neuroectodermal Tumors, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡